Response to the letter to the editor: Methodological considerations on “Comparison of dexmedetomidine and morphine versus plain ropivacaine 0.2% for myofascial infiltration in thoracolumbar spinal fusion: a double-blind randomized trial” | Synapse
July 2, 2026Open Access
Response to the letter to the editor: Methodological considerations on “Comparison of dexmedetomidine and morphine versus plain ropivacaine 0.2% for myofascial infiltration in thoracolumbar spinal fusion: a double-blind randomized trial”
Puntos clave
The aim was to analyze pain management efficacy during thoracolumbar spinal fusion surgery.
Conducted a randomized double-blind trial comparing dexmedetomidine and morphine to ropivacaine for myofascial infiltration.
Focused on patients undergoing single-level or two-to-three-level spine fusion surgery.
Subgroup analysis indicated consistent trends in analgesic outcomes between the treatment groups during surgery.
Resumen
Subgroup analysis further revealed a consistent trend among patients undergoing single-level or two-to three-level spine fusion surgery.